A non-invasive, urine-sample-based diagnostic kit for prostate cancer detection and risk assessment. The kit utilizes PSA N-glycosylation analysis to detect asparagine-linked carbohydrates of PSA, providing comprehensive clinical insights into prostate cancer-related alterations. It employs recombin...
Manufactured by
Veszprém, Hungary
iPASy is revolutionizing prostate cancer screening with a urine-based, non-invasive diagnostic that detects disease-specific glycan patterns of urinary PSA, offering up to six-times higher specificity than blood-based tests. Our vision is to make prostate cancer detection accurate, accessible, and patient-friendly worldwide , with upcoming launches in Europe and the U.S. in collaboration with Mayo Clinic .
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Zybio Inc.
China · 1 relevant product
BEACON DIAGNOSTICS PVT. LTD.
India · 1 relevant product
Berkeley Health Ltd
United Kingdom · 2 relevant products
Shenzhen Microprofit Biotech Co., Ltd
China · 1 relevant product
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 1 relevant product
J. Mitra & Co. Pvt. Ltd.
India · 1 relevant product
Diagnostics Biochem Canada Inc.
Canada · 2 relevant products
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 3 relevant products
HANGZHOU LAIHE BIOTECH CO.,LTD
China · 2 relevant products
SHMY HEALTHDIGIT BIOCHIPS CO.,LTD
China · 1 relevant product
72 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 108 closest product alternatives
Zybio Inc. · China
Immunoassay for prostate-specific antigen measurement in prostate cancer screening. Provides quantitative measurement for clinical decision-making.
BEACON DIAGNOSTICS PVT. LTD. · India
Prostate-specific antigen assay for screening and monitoring of prostate cancer. Quantitative measurement of PSA in serum samples.
Berkeley Health Ltd · United Kingdom
Rapid home test kit for semi-quantitative detection of prostate-specific antigen in human whole blood. Enables self-screening for prostate health status with results available within 15 minutes. ISO 13485:2016 certified for accuracy and reliability.
Shenzhen Microprofit Biotech Co., Ltd · China
FIA-based quantitative test kit for PSA measurement in prostate health screening. Designed for point-of-care testing applications.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
A lateral flow immunoassay test kit for detection of prostate-specific antigen levels. This test aids in prostate health screening and early detection of abnormalities.
J. Mitra & Co. Pvt. Ltd. · India
Chemiluminescence immunoassay for total prostate-specific antigen measurement with analytical sensitivity of 0.005 ng/ml and linearity up to 100 ng/ml.
Diagnostics Biochem Canada Inc. · Canada
An enzyme-linked immunosorbent assay (ELISA) kit for the quantitative measurement of free prostate specific antigen in human serum samples. The assay has an assay time of 75 minutes, a shelf stability of 18 months, and a sensitivity of 0.05 ng/mL. Reference: CAN-FPSA-4400.
Diagnostics Biochem Canada Inc. · Canada
An enzyme-linked immunosorbent assay (ELISA) kit for the quantitative measurement of total prostate specific antigen in human serum samples. The assay has an assay time of 105 minutes, a shelf stability of 12 months, and a sensitivity of 0.1 ng/mL. Reference: CAN-TPSA-4300.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
In vitro diagnostic test for identifying and quantifying cancer-related biomarkers. Supports oncology diagnosis, prognosis, and treatment monitoring.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
Rapid screening assays for AFP, CEA, PSA, and other key oncology markers enabling accessible, early-stage risk stratification in community health screening and specialist oncology settings. Offers quantitative fluorescence and semi-quantitative formats with low sample volume requirements of 50–100 µL serum/plasma. Multi-marker combo panels are available.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Diagnostic kit for analyzing cancer-related genetic mutations and biomarkers. Provides genomic information to support targeted therapy selection and treatment planning.
SHMY HEALTHDIGIT BIOCHIPS CO.,LTD · China
Multi-tumor marker detection kit utilizing protein chip technology with chemiluminescence for simultaneous identification of multiple cancer biomarkers in blood and serum samples. Designed for clinical diagnosis and monitoring of various malignancies, this in vitro diagnostic test enables rapid quantitative analysis to support oncology patient management and treatment decisions.
96 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products